ENLV Enlivex Therapeutics Ltd.

Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

$4.52  -0.19 (-4.03%)
As of 06/30/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  
IPO date:  11/02/2017
Outstanding shares:  18,373,427
Average volume:  39,219
Market cap:   $86,538,841
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.97
PS ratio:   0.00
Return on equity:   -17.01%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy